Multiply doses of FDC of rosuvastatin and ezetimibe versus rosuvastatin monotherapy in Chinese patients with hypercholesterolemia (ROSE-CH): multicenter, randomized-controlled trial

ABSTRACT:

SUBMITTER: Ji X 

PROVIDER: S-EPMC12281852 | biostudies-literature | 2025 Jan

REPOSITORIES: biostudies-literature